SEC Form 4 · accession 0001127602-18-006418
Bioverativ Inc. · BIVV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John Cox
Officer — Chief Executive Officer · Director
Period of report
Feb 14, 2018
Accepted (ET)
Feb 15, 2018 · 5:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 14, 2018 | M | 24,339 | $0.00 | A | 215,680 | D | |
| Common StockF1 | Feb 14, 2018 | F | 10,819 | $103.52 | D | 204,861 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF2,F3 | — | Feb 14, 2018 | M | 24,339 | D | — | — | Common Stock | 24,339 | 48,678 | D |
Explanation of responses
- F1Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units.
- F2Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- F3The restricted stock units vest in three equal annual installments beginning on February 14, 2018.